Who owns Kimberly-Clark de Mexico, S.A.B. de C.V. (KCM)

Kimberly-Clark de Mexico, S.A.B. de C.V. (KCM) - Profile

Kimberly-Clark de Mexico is a Mexico City based maker of disposable personal care and tissue products, listed on the Bolsa Mexicana de Valores under the ticker KIMBER A. It runs two businesses: a consumer arm selling diapers, training pants, wet wipes, feminine care, adult incontinence products, bath tissue, facial tissue, napkins and paper towels, and a professional arm supplying away from home hygiene products to businesses and institutions. Its brands include Kleenex, Huggies, KleenBebe, Kotex, Cottonelle, Depend, Kimlark, Petalo, Escudo and Sanitas. The company traces to the La Aurora paper mill founded in 1925 and took its modern form after 1959, and it operates plants at sites including Naucalpan, Ecatepec, Morelia, San Rafael and Texmelucan. It employs roughly 8,000 people directly and reported revenue of 53.3 billion Mexican pesos with net income of 7.0 billion pesos in 2023.

The disclosed stakes

One row per position. Where a holder reports the same company in two share classes, both rows are shown rather than summed, because the class is part of a position's identity.

Where each figure comes from

A private stake has no ownership form behind it, so the source is always the holder's own filing or disclosure. Anything modelled says so, with the arithmetic.

• Kimberly-Clark Corporation, as of 31 Dec 2025. FY2025 10-K, Investments in Equity Companies note: 'As of December 31, 2025, our ownership interest in Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries ("KCM") was 47.9%. KCM is partially owned by the public, and its stock is publicly traded in Mexico. As of December 31, 2025, our investment in this equity company was $266, and the estimated fair value of the investment was $2.9 billion based on the market price of publicly traded shares.' The $266 million figure is the carrying (cost-plus-equity-in-undistributed-income) value under equity method accounting, not fair value; value_usd here uses the $2.9 billion market-based fair value instead, since that is the figure tied to KCM's own traded share price. No share count or per-share price is disclosed for KMB's KCM stake, so shares and value_price_per_share stay null. The Q2 2026 10-Q does not break KCM out separately: its balance sheet shows only a combined 'Investments in Equity Companies' balance of $381 million at 30 June 2026 (up from $330 million at 31 Dec 2025) covering all equity-method affiliates together, so that more recent combined figure is not usable for a KCM-specific value per the rule against assigning a combined balance to one investee. The 10-K states separately that 'our other equity ownership interests are not significant,' confirming KCM is the only individually material equity-method holding. source